Girish Mahajan (Editor)

Cartazolate

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Routes of administration  By mouth
CAS Number  34966-41-1
ChemSpider  33966
Route  Oral administration
ATC code  None
PubChem CID  37015
Molar mass  290.36 g/mol
Cartazolate
Legal status  In general: uncontrolled

How to pronounce cartazolate


Cartazolate (SQ-65,396) is a drug of the pyrazolopyridine class. It acts as a GABAA receptor positive allosteric modulator at the barbiturate binding site of the complex and has anxiolytic effects in animals. It is also known to act as an adenosine antagonist at the A1 and A2 subtypes and as a phosphodiesterase inhibitor. Cartazolate was tested in human clinical trials and was found to be efficacious for anxiety but was never marketed. It was developed by a team at E.R. Squibb and Sons in the 1970s.

Contents

Synthesis

Condensation of aminopyrazole (1) with diethyl ethoxymethylenemalonate (2) gives the product of the addition-elimination (3). The product tautomerizes spontaneously to the hydroxypyridine (4). The hydroxyl group is then converted to the chloro-derivative by means of phosphorus oxychloride (5). Displacement of halogen by n-butylamine gives the antidepressant compound cartazolate. Displacement of halogen by the basic nitrogen of acetone hydrazone affords the antidepressant etazolate.

References

Cartazolate Wikipedia


Similar Topics
Disraeli (1929 film)
Ashim Ahluwalia
Max Plaxton
Topics
 
B
i
Link
H2
L